Oh Andrew M. Insider Trades

Insider Trading History

Track insider trading activity for Oh Andrew M.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $3.2 16,000 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 6,000 shares
$5.30
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $2.4 12,000 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2k 6,000 shares
$3.70
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.6 8,000 shares
Last Trade
Sep 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.88k 8,000 shares
$0.73
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $2.4 12,000 shares
Last Trade
Sep 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.82k 12,000 shares
$0.73
$0.00
Rubius Therapeutics
Rubius Therapeutics RUBY
Chief Financial Officer
Holding Value $43.1k 755,500 shares
Last Trade
May 15, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28k 5,000 shares
$5.60
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Chief Financial Officer
Holding Value $285 5,000 shares
Last Trade
May 15, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28k 5,000 shares
$5.60
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Chief Financial Officer
Holding Value $9.41k 165,000 shares
Last Trade
Jan 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.29M 165,000 shares
$7.80
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Chief Financial Officer
Holding Value $6.56k 115,000 shares
Last Trade
Jan 31, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.57M 115,000 shares
$13.69
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jul 17, 2018 Sale
No data
No data
$0.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up